Skip to main content

Published locations for Zanubrutinib elicits favorable long-term responses in relapsed or refractory CLL or SLL

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Zanubrutinib elicits favorable long-term responses in relapsed or refractory CLL or SLL

User login

  • Reset your password
  • /content/zanubrutinib-elicits-favorable-long-term-responses-relapsed-or-refractory-cll-or-sll
  • /hematology-oncology/article/262007/b-cell-lymphoma/zanubrutinib-elicits-favorable-long-term
  • /breast-cancer-icymi/article/262007/breast-cancer/zanubrutinib-elicits-favorable-long-term-responses
  • /b-cell-lymphoma-icymi/article/262007/b-cell-lymphoma/zanubrutinib-elicits-favorable-long-term